Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)
0.2400
-0.0020 (-0.83%)
At close: Jun 25, 2026
XSAT:ISAB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.39 | 2.83 | 4.45 | 7.83 | 1.84 | 14.4 |
Cash & Short-Term Investments | 3.39 | 2.83 | 4.45 | 7.83 | 1.84 | 14.4 |
Cash Growth | 5.94% | -36.31% | -43.20% | 325.50% | -87.22% | 78.89% |
Accounts Receivable | 1.27 | 1 | 1.4 | 3.81 | 2.66 | 2.6 |
Other Receivables | 2.17 | 0.53 | 0.25 | 0.5 | 0.24 | 0.52 |
Receivables | 3.44 | 1.53 | 1.65 | 4.31 | 2.89 | 3.11 |
Inventory | 2.61 | 3.09 | 2.92 | 3.24 | 4.24 | 3.52 |
Prepaid Expenses | 1.14 | 1.28 | 0.26 | 0.42 | 0.53 | 0.45 |
Total Current Assets | 10.58 | 8.74 | 9.28 | 15.8 | 9.5 | 21.48 |
Property, Plant & Equipment | 0.38 | 0.4 | 0.51 | 0.65 | 0.84 | 1.04 |
Long-Term Deferred Charges | 0.33 | 0.39 | 0.74 | 1.72 | 2.65 | 3.59 |
Other Long-Term Assets | - | - | - | - | - | 0 |
Total Assets | 11.28 | 9.53 | 10.53 | 18.17 | 12.99 | 26.11 |
Accounts Payable | 1.28 | 0.47 | 0.92 | 1.08 | 1.75 | 2.26 |
Accrued Expenses | 1.6 | 0.42 | 0.67 | 1.22 | 1.08 | 1.5 |
Current Portion of Long-Term Debt | - | - | 0.44 | 0.65 | 0.48 | 0.48 |
Current Unearned Revenue | - | 0.6 | 0.12 | 1 | 0.47 | 0.18 |
Other Current Liabilities | 0.24 | 0.78 | 0.58 | 0.82 | 0.8 | 0.65 |
Total Current Liabilities | 3.12 | 2.27 | 2.72 | 4.77 | 4.57 | 5.07 |
Long-Term Debt | - | - | - | 0.44 | 0.86 | 1.37 |
Total Liabilities | 3.12 | 2.27 | 2.72 | 5.21 | 5.43 | 6.43 |
Common Stock | 1.46 | 1.29 | 6.07 | 6.07 | 4.55 | 4.55 |
Additional Paid-In Capital | 106.23 | 104.33 | 94.71 | 94.71 | 82.73 | 82.55 |
Retained Earnings | -100.09 | -98.75 | -93.71 | -89.55 | -83.08 | -70.96 |
Comprehensive Income & Other | 0.56 | 0.39 | 0.74 | 1.72 | 3.36 | 3.54 |
Shareholders' Equity | 8.16 | 7.26 | 7.81 | 12.95 | 7.55 | 19.68 |
Total Liabilities & Equity | 11.28 | 9.53 | 10.53 | 18.17 | 12.99 | 26.11 |
Total Debt | - | - | 0.44 | 1.09 | 1.34 | 1.85 |
Net Cash (Debt) | 3.39 | 2.83 | 4 | 6.74 | 0.5 | 12.55 |
Net Cash Growth | 16.14% | -29.28% | -40.56% | 1244.31% | -96.01% | 116.31% |
Net Cash Per Share | 0.10 | 0.10 | 0.26 | 0.51 | 0.04 | 1.24 |
Filing Date Shares Outstanding | 44.3 | 39.17 | 15.17 | 15.17 | 11.38 | 11.38 |
Total Common Shares Outstanding | 44.3 | 39.17 | 15.17 | 15.17 | 11.38 | 11.38 |
Working Capital | 7.46 | 6.47 | 6.56 | 11.02 | 4.92 | 16.42 |
Book Value Per Share | 0.18 | 0.19 | 0.51 | 0.85 | 0.66 | 1.73 |
Tangible Book Value | 8.16 | 7.26 | 7.81 | 12.95 | 7.55 | 19.68 |
Tangible Book Value Per Share | 0.18 | 0.19 | 0.51 | 0.85 | 0.66 | 1.73 |
Machinery | - | 2.61 | 2.61 | 2.61 | 2.61 | 2.91 |